Share-based Payment Arrangement, Expense in USD of Deciphera Pharmaceuticals, Inc. from 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2015 to Q1 2024.
  • Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $10.2M, a 18.7% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2024 was $48.3M, a 3.84% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $50.6M, a 2.58% decline from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $51.9M, a 12.7% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $46.1M, a 24.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Deciphera Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $48.3M $10.2M -$2.34M -18.7% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024
Q4 2023 $50.6M $14.1M +$1.76M +14.3% 01 Oct 2023 31 Dec 2023 10-K 07 Feb 2024
Q3 2023 $48.8M $11.2M -$1.21M -9.8% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2023
Q2 2023 $50.1M $12.9M -$132K -1.02% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $50.2M $12.5M -$1.75M -12.3% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $51.9M $12.3M +$1.52M +14.1% 01 Oct 2022 31 Dec 2022 10-K 07 Feb 2024
Q3 2022 $50.4M $12.4M +$579K +4.91% 01 Jul 2022 30 Sep 2022 10-Q 30 Oct 2023
Q2 2022 $49.8M $13M +$617K +4.99% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $49.2M $14.3M +$3.15M +28.3% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $46.1M $10.8M +$1.09M +11.2% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024
Q3 2021 $45M $11.8M +$1.97M +20% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $43M $12.4M +$1.76M +16.6% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $41.3M $11.1M +$4.13M +59% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $37.1M $9.71M +$4.36M +81.6% 01 Oct 2020 31 Dec 2020 10-K 07 Feb 2023
Q3 2020 $32.8M $9.83M +$5.1M +108% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 $27.7M $10.6M +$6.5M +158% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $21.2M $6.99M +$765K +12.3% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $20.4M $5.35M +$2.54M +90.6% 01 Oct 2019 31 Dec 2019 10-K 08 Feb 2022
Q3 2019 $17.9M $4.73M +$2.12M +80.9% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $15.8M $4.11M +$1.88M +84% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020
Q1 2019 $13.9M $6.23M +$4.19M +206% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q4 2018 $9.69M $2.81M -$39K -1.37% 01 Oct 2018 31 Dec 2018 10-K 09 Feb 2021
Q3 2018 $9.73M $2.61M +$1.6M +158% 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019
Q2 2018 $8.13M $2.23M +$1.64M +276% 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019
Q1 2018 $6.49M $2.04M +$1.62M +390% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $4.87M $2.84M 01 Oct 2017 31 Dec 2017 10-K 09 Mar 2020
Q3 2017 $1.01M 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 $594K 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018
Q1 2017 $416K 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018

Deciphera Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $50.6M -$1.34M -2.58% 01 Jan 2023 31 Dec 2023 10-K 07 Feb 2024
2022 $51.9M +$5.86M +12.7% 01 Jan 2022 31 Dec 2022 10-K 07 Feb 2024
2021 $46.1M +$8.94M +24.1% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024
2020 $37.1M +$16.7M +82% 01 Jan 2020 31 Dec 2020 10-K 07 Feb 2023
2019 $20.4M +$10.7M +111% 01 Jan 2019 31 Dec 2019 10-K 08 Feb 2022
2018 $9.69M +$4.82M +99.1% 01 Jan 2018 31 Dec 2018 10-K 09 Feb 2021
2017 $4.87M +$3.38M +227% 01 Jan 2017 31 Dec 2017 10-K 09 Mar 2020
2016 $1.49M -$1.07M -41.8% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 $2.56M 01 Jan 2015 31 Dec 2015 10-K 28 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.